591 related articles for article (PubMed ID: 29936118)
21. Highly specific delivery of siRNA to hepatocytes circumvents endothelial cell-mediated lipid nanoparticle-associated toxicity leading to the safe and efficacious decrease in the hepatitis B virus.
Sato Y; Matsui H; Yamamoto N; Sato R; Munakata T; Kohara M; Harashima H
J Control Release; 2017 Nov; 266():216-225. PubMed ID: 28986168
[TBL] [Abstract][Full Text] [Related]
22. A QCM-D and SAXS Study of the Interaction of Functionalised Lyotropic Liquid Crystalline Lipid Nanoparticles with siRNA.
Tajik-Ahmadabad B; Mechler A; Muir BW; McLean K; Hinton TM; Separovic F; Polyzos A
Chembiochem; 2017 May; 18(10):921-930. PubMed ID: 28233412
[TBL] [Abstract][Full Text] [Related]
23. A Multifunctional Envelope-Type Nano Device Containing a pH-Sensitive Cationic Lipid for Efficient Delivery of Short Interfering RNA to Hepatocytes In Vivo.
Sato Y; Harashima H; Kohara M
Methods Mol Biol; 2016; 1364():71-8. PubMed ID: 26472443
[TBL] [Abstract][Full Text] [Related]
24. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.
Cheng X; Lee RJ
Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):129-137. PubMed ID: 26900977
[TBL] [Abstract][Full Text] [Related]
25. Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery.
Kimura N; Maeki M; Sato Y; Ishida A; Tani H; Harashima H; Tokeshi M
ACS Appl Mater Interfaces; 2020 Jul; 12(30):34011-34020. PubMed ID: 32667806
[TBL] [Abstract][Full Text] [Related]
26. Nanometer-scale siRNA carriers incorporating peptidomimetic oligomers: physical characterization and biological activity.
Konca YU; Kirshenbaum K; Zuckermann RN
Int J Nanomedicine; 2014; 9():2271-85. PubMed ID: 24872690
[TBL] [Abstract][Full Text] [Related]
27. Chitosan-lipid nanoparticles (CS-LNPs): Application to siRNA delivery.
Tezgel Ö; Szarpak-Jankowska A; Arnould A; Auzély-Velty R; Texier I
J Colloid Interface Sci; 2018 Jan; 510():45-56. PubMed ID: 28934610
[TBL] [Abstract][Full Text] [Related]
28. Design and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA delivery.
Malamas AS; Gujrati M; Kummitha CM; Xu R; Lu ZR
J Control Release; 2013 Nov; 171(3):296-307. PubMed ID: 23796431
[TBL] [Abstract][Full Text] [Related]
29. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
Gujrati M; Vaidya A; Lu ZR
Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
[TBL] [Abstract][Full Text] [Related]
30. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
[TBL] [Abstract][Full Text] [Related]
31. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D
ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928
[TBL] [Abstract][Full Text] [Related]
32. Next-Generation Lipids in RNA Interference Therapeutics.
Rietwyk S; Peer D
ACS Nano; 2017 Aug; 11(8):7572-7586. PubMed ID: 28727419
[TBL] [Abstract][Full Text] [Related]
33. The development of tertiary amine cationic lipids for safe and efficient siRNA delivery.
Lin Z; Bao M; Yu Z; Xue L; Ju C; Zhang C
Biomater Sci; 2019 Jul; 7(7):2777-2792. PubMed ID: 31041934
[TBL] [Abstract][Full Text] [Related]
34. Insight into mechanisms of cellular uptake of lipid nanoparticles and intracellular release of small RNAs.
Yu B; Wang X; Zhou C; Teng L; Ren W; Yang Z; Shih CH; Wang T; Lee RJ; Tang S; Lee LJ
Pharm Res; 2014 Oct; 31(10):2685-95. PubMed ID: 24740244
[TBL] [Abstract][Full Text] [Related]
35. Lipid-Based Liquid Crystalline Nanoparticles Facilitate Cytosolic Delivery of siRNA via Structural Transformation.
He S; Fan W; Wu N; Zhu J; Miao Y; Miao X; Li F; Zhang X; Gan Y
Nano Lett; 2018 Apr; 18(4):2411-2419. PubMed ID: 29561622
[TBL] [Abstract][Full Text] [Related]
36. Airway epithelial cell-specific delivery of lipid nanoparticles loading siRNA for asthma treatment.
Zhang M; Jiang H; Wu L; Lu H; Bera H; Zhao X; Guo X; Liu X; Cun D; Yang M
J Control Release; 2022 Dec; 352():422-437. PubMed ID: 36265740
[TBL] [Abstract][Full Text] [Related]
37. Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery.
Whitehead KA; Sahay G; Li GZ; Love KT; Alabi CA; Ma M; Zurenko C; Querbes W; Langer RS; Anderson DG
Mol Ther; 2011 Sep; 19(9):1688-94. PubMed ID: 21750531
[TBL] [Abstract][Full Text] [Related]
38. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.
Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM
Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715
[TBL] [Abstract][Full Text] [Related]
39. [Development of an efficient short interference RNA (siRNA) delivery system with a new pH-sensitive cationic lipid].
Sato Y; Hatakeyama H; Hyodo M; Akita H; Harashima H
Yakugaku Zasshi; 2012; 132(12):1355-63. PubMed ID: 23208041
[TBL] [Abstract][Full Text] [Related]
40. Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells.
Khare P; Dave KM; Kamte YS; Manoharan MA; O'Donnell LA; Manickam DS
AAPS J; 2021 Dec; 24(1):8. PubMed ID: 34873640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
